These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31523183)

  • 41. Investigation of scrambled ions in tandem mass spectra, part 2. On the influence of the ions on peptide identification.
    Dong NP; Liang YZ; Yi LZ; Lu HM
    J Am Soc Mass Spectrom; 2013 Jun; 24(6):857-67. PubMed ID: 23504644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing peptide de novo sequencing algorithms performance on large and diverse data sets.
    Pitzer E; Masselot A; Colinge J
    Proteomics; 2007 Sep; 7(17):3051-4. PubMed ID: 17683051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. De novo sequencing methods in proteomics.
    Hughes C; Ma B; Lajoie GA
    Methods Mol Biol; 2010; 604():105-21. PubMed ID: 20013367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CycloBranch: De Novo Sequencing of Nonribosomal Peptides from Accurate Product Ion Mass Spectra.
    Novák J; Lemr K; Schug KA; Havlíček V
    J Am Soc Mass Spectrom; 2015 Oct; 26(10):1780-6. PubMed ID: 26195308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De novo peptide sequencing via manual interpretation of MS/MS spectra.
    Addona T; Clauser K
    Curr Protoc Protein Sci; 2002 May; Chapter 16():Unit 16.11. PubMed ID: 18429223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transformer-based de novo peptide sequencing for data-independent acquisition mass spectrometry.
    Ebrahimi S; Guo X
    Proc IEEE Int Symp Bioinformatics Bioeng; 2023 Dec; 2023():28-35. PubMed ID: 38665266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transformer-based de novo peptide sequencing for data-independent acquisition mass spectrometry.
    Ebrahimi S; Guo X
    ArXiv; 2024 Jun; ():. PubMed ID: 38659639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry.
    Ma B; Zhang K; Hendrie C; Liang C; Li M; Doherty-Kirby A; Lajoie G
    Rapid Commun Mass Spectrom; 2003; 17(20):2337-42. PubMed ID: 14558135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De Novo Sequencing Assisted Approach for Characterizing Mixture MS/MS Spectra.
    Liu Y; Sun W; John J; Lajoie G; Ma B; Zhang K
    IEEE Trans Nanobioscience; 2016 Mar; 15(2):166-76. PubMed ID: 26800542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DeNovoID: a web-based tool for identifying peptides from sequence and mass tags deduced from de novo peptide sequencing by mass spectroscopy.
    Halligan BD; Ruotti V; Twigger SN; Greene AS
    Nucleic Acids Res; 2005 Jul; 33(Web Server issue):W376-81. PubMed ID: 15980493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. De novo peptide sequencing by deep learning.
    Tran NH; Zhang X; Xin L; Shan B; Li M
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8247-8252. PubMed ID: 28720701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fast de novo peptide sequencing and spectral alignment via tree decomposition.
    Liu C; Song Y; Yan B; Xu Y; Cai L
    Pac Symp Biocomput; 2006; ():255-66. PubMed ID: 17094244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MUMAL2: Improving sensitivity in shotgun proteomics using cost sensitive artificial neural networks and a threshold selector algorithm.
    Cerqueira FR; Ricardo AM; de Paiva Oliveira A; Graber A; Baumgartner C
    BMC Bioinformatics; 2016 Dec; 17(Suppl 18):472. PubMed ID: 28105913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-confidence de novo peptide sequencing using positive charge derivatization and tandem MS spectra merging.
    An M; Zou X; Wang Q; Zhao X; Wu J; Xu LM; Shen HY; Xiao X; He D; Ji J
    Anal Chem; 2013 May; 85(9):4530-7. PubMed ID: 23536960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paired single residue-transposed Lys-N and Lys-C digestions for label-free identification of N-terminal and C-terminal MS/MS peptide product ions: ultrahigh resolution Fourier transform ion cyclotron resonance mass spectrometry and tandem mass spectrometry for peptide de novo sequencing.
    Brownstein NC; Guan X; Mao Y; Zhang Q; DiMaggio PA; Xia Q; Zhang L; Marshall AG; Young NL
    Rapid Commun Mass Spectrom; 2015 Apr; 29(7):659-66. PubMed ID: 26212284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. De novo peptide sequencing via tandem mass spectrometry.
    Dancík V; Addona TA; Clauser KR; Vath JE; Pevzner PA
    J Comput Biol; 1999; 6(3-4):327-42. PubMed ID: 10582570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PGPointNovo: an efficient neural network-based tool for parallel
    Xu X; Yang C; He Q; Shu K; Xinpu Y; Chen Z; Zhu Y; Chen T
    Bioinform Adv; 2023; 3(1):vbad057. PubMed ID: 37128577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PRESnovo: Prescreening Prior to
    DeLaney K; Cao W; Ma Y; Ma M; Zhang Y; Li L
    J Am Soc Mass Spectrom; 2020 Jul; 31(7):1358-1371. PubMed ID: 32266812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complexity and scoring function of MS/MS peptide de novo sequencing.
    Xu C; Ma B
    Comput Syst Bioinformatics Conf; 2006; ():361-9. PubMed ID: 17369655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptide de novo sequencing of mixture tandem mass spectra.
    Gorshkov V; Hotta SY; Verano-Braga T; Kjeldsen F
    Proteomics; 2016 Sep; 16(18):2470-9. PubMed ID: 27329701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.